Corteva (CTVA) AI Stock Analysis

• Market Cap: $52.53B
• Dividend Yield: 0.88%
• Average Volume (3M): 4.14M
• Price to Earnings (P/E): 46.9
• Beta (1Y): 0.65
• Revenue Growth: >-0.01%
• EPS Growth: 108.45%
• Country: US
• Employees: 22,000
• Sector: Basic Materials
• Sector Strength: 73
• Industry: Agricultural Inputs
• EPS (TTM): 1.13
• Shares Outstanding: 682,170,000
• 10 Day Avg. Volume: 5,388,924
• 30 Day Avg. Volume: 4,137,979
• PEG Ratio: -1.10
• Price to Book (P/B): 1.67
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 158.68
• Enterprise Value/Market Cap: 0.77
• Enterprise Value/Revenue: 0.60
• Enterprise Value/Gross Profit: 5.39
• Enterprise Value/Ebitda: 3.82
• 1Y Price Target: $76.18
• Price Target Upside: -1.06% Downside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 13

• Rating: 73 Outperform
• Price Target: $86.00 ▲(11.69%Upside)

Corteva's overall stock score of 73 reflects its strong financial performance and positive earnings outlook. The company's cash flow and balance sheet are solid, and it has effective operational strategies. However, overvaluation concerns and technical indicators suggest potential short-term volatility.

Positive Factors

Earnings Performance

CTVA reported a solid 1Q earnings beat on margin expansion across both segments.

Product Offering

Strategic agreement with FMC for Fluidapyr fungicide enhances CTVA's product offering.

Sector Tailwinds

CTVA is best-positioned to benefit from ag sector tailwinds.

Strategic Partnerships

The collaboration with FMC is an incremental positive for growth.

Negative Factors

Interest Rate Sensitivity

Corteva's multiple expansion can continue, as it is less sensitive to interest rates compared to construction and auto sectors.

Tariff Concerns

CTVA noted its guidance does not reflect any tariff effects, and does not expect a material net impact to full year 2025 results.

Corteva Business Overview & Revenue Model

Company Description

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

How the Company Makes Money

Corteva generates revenue primarily through the sale of its seed and crop protection products. The Seed segment focuses on producing and selling a variety of seeds, including corn, soybean, and sunflower, which are engineered to improve yield and resist pests and diseases. The Crop Protection segment offers a range of products such as herbicides, insecticides, and fungicides, which help protect crops from weeds, insects, and disease. Additionally, Corteva leverages digital agriculture technologies that provide data-driven insights to optimize farming practices. The company benefits from strategic partnerships and a strong distribution network, allowing it to effectively reach global markets and support its earnings growth.

Corteva Financial Statement Overview

Summary

Corteva exhibits a solid financial position with strong cash flow generation and a stable balance sheet. While profitability margins show room for improvement, the company's low leverage and healthy equity ratio provide a stable foundation. The consistent cash flow performance supports future growth and strategic initiatives.

Income Statement

Corteva shows a solid performance with a stable revenue base in the TTM period. The gross profit margin stands at 44.6%, indicating efficient cost management, while the net profit margin is 6.8%, reflecting reasonable profitability. However, there is a slight decline in revenue from the previous year. The EBIT margin of 13.4% and EBITDA margin of 17.9% demonstrate healthy operational efficiency, although there's room for improvement in net profitability.

Balance Sheet

The balance sheet is robust, with a debt-to-equity ratio of 0.17, indicating low leverage and financial stability. The return on equity (ROE) is 4.7%, showing moderate returns for shareholders. The equity ratio is a strong 57.7%, reflecting a solid capital structure. Overall, the company maintains a healthy balance sheet with manageable debt levels.

Cash Flow

Corteva's cash flow is strong, with a free cash flow growth rate of 35.8% in the TTM period, highlighting effective cash generation. The operating cash flow to net income ratio is 2.32, showcasing excellent cash conversion capability. The free cash flow to net income ratio of 1.84 further underscores the company's ability to generate free cash relative to its net income. This positions the company well for potential reinvestment or debt servicing.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	16.83B	16.91B	17.23B	17.45B	15.65B	14.22B
Gross Profit	7.51B	7.38B	7.31B	7.02B	6.43B	5.71B
EBITDA	3.02B	2.73B	2.54B	2.73B	3.62B	1.90B
Net Income	1.14B	907.00M	735.00M	1.15B	1.76B	681.00M
Balance Sheet
Total Assets	42.12B	40.83B	43.00B	42.62B	42.34B	42.65B
Cash, Cash Equivalents and Short-Term Investments	2.01B	3.17B	2.74B	3.31B	4.54B	3.79B
Total Debt	4.08B	2.70B	2.49B	1.31B	1.12B	1.11B
Total Liabilities	17.60B	16.80B	17.72B	17.08B	16.72B	17.59B
Stockholders Equity	24.29B	23.79B	25.04B	25.30B	25.38B	24.82B
Cash Flow
Free Cash Flow	2.10B	1.55B	1.17B	267.00M	2.15B	1.59B
Operating Cash Flow	2.65B	2.15B	1.77B	872.00M	2.73B	2.06B
Investing Cash Flow	-353.00M	-589.00M	-1.99B	-632.00M	-362.00M	-674.00M
Financing Cash Flow	-1.97B	-1.20B	-99.00M	-1.18B	-1.27B	303.00M

Corteva Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 77.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTVA, the sentiment is Positive. The current price of 77 is above the 20-day moving average (MA) of 73.65, above the 50-day MA of 69.29, and above the 200-day MA of 62.18, indicating a bullish trend. The MACD of 1.88 indicates Negative momentum. The RSI at 79.92 is Negative, neither overbought nor oversold. The STOCH value of 95.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CTVA.

Corteva Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CF	75 Outperform	$15.20B	12.38	26.14%	2.13%	0.66%	25.75%
CTVA	73 Outperform	$52.53B	46.95	4.66%	0.88%	>-0.01%	108.45%
ICL	70 Neutral	$9.31B	23.91	6.70%	2.39%	-3.48%	-18.34%
FMC	69 Neutral	$5.52B	16.98	8.81%	5.22%	1.45%	-70.85%
MOS	69 Neutral	$11.99B	32.63	3.09%	2.33%	-13.37%	-50.63%
SMG	57 Neutral	$3.98B	137.72	4.98%	3.83%	0.75%	―
Sector *	44 Neutral	C$976.20M	-6.71	-13.35%	2.69%	17.20%	-32.62%

Corteva Corporate Events

Corteva Stockholders Approve Key Proposals at Annual Meeting

On April 30, 2025, Corteva, Inc. held its Annual Meeting of Stockholders, where 89.05% of the company’s outstanding shares were voted. During the meeting, stockholders elected 12 directors, approved executive compensation, and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025.